GLP-1 side effects (nausea, vomiting, constipation) are generally well-tolerated and diminish over time
Provisional Physician Licenses Senate Bill 137 would allow the state Board of Medical Licensure to issue a provisional license to a physician who completed residency in a foreign country and can meet other requirements
Furthermore, studies have shown that GLP-1 agonists reduce liver-associated mortality in T2DM patients [87]
Food and Drug Administration (FDA) has recognized the potential of GLP-1 agonists for weight loss by approving medications like semaglutide and liraglutide (Saxenda) specifically for this purpose
Roychowdhury S, McCullough RL, Sanz-Garcia C, Saikia P, Alkhouri N, Matloob A, et al
DWAT is a layer of adipocytes with metabolic activity, immune cells, fibroblasts and ADSCs in the dermis